Applied Dna Sciences Inc (NASDAQ:APDN) Institutional Investors Sentiment Index Up in 2016 Q4

June 20, 2017 - By Vivian Park

 Applied Dna Sciences Inc (NASDAQ:APDN) Institutional Investors Sentiment Index  Up in  2016 Q4

Sentiment for Applied Dna Sciences Inc (NASDAQ:APDN)

Applied Dna Sciences Inc (NASDAQ:APDN) institutional sentiment increased to 1.33 in Q4 2016. Its up 0.33, from 1 in 2016Q3. The ratio is positive, as 12 institutional investors opened new or increased positions, while 9 sold and reduced their positions in Applied Dna Sciences Inc. The institutional investors in our partner’s database reported: 3.85 million shares, up from 1.70 million shares in 2016Q3. Also, the number of institutional investors holding Applied Dna Sciences Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 5 Increased: 6 New Position: 6.

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The company has market cap of $23.82 million. The Firm is also engaged in the large-scale production of specific deoxyribonucleic acid sequences using the polymerase chain reaction (PCR). It currently has negative earnings. The Company’s principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

It is down 49.09% since June 20, 2016 and is downtrending. It has underperformed by 65.79% the S&P500.

Sabby Management Llc holds 0.23% of its portfolio in Applied DNA Sciences Inc for 2.11 million shares. Benchmark Capital Advisors owns 138,000 shares or 0.21% of their US portfolio. Moreover, Anson Funds Management Lp has 0.08% invested in the company for 143,838 shares. The Virginia-based Chase Investment Counsel Corp has invested 0.07% in the stock. Dumont & Blake Investment Advisors Llc, a New Jersey-based fund reported 20,921 shares.#img1#

More notable recent Applied DNA Sciences Inc (NASDAQ:APDN) news were published by: Seekingalpha.com which released: “Applied DNA Sciences’ (APDN) CEO James Hayward on Q4 2016 Results – Earnings …” on December 07, 2016, also Reuters.com with their article: “BRIEF-Applied DNA Sciences reports Q2 loss per share $0.13” published on May 11, 2017, Seekingalpha.com published: “Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2017 Results – Earnings …” on May 12, 2017. More interesting news about Applied DNA Sciences Inc (NASDAQ:APDN) were released by: Marketwired.com and their article: “Applied DNA Sciences Appoints Dr. Mehmood Khan to Company’s Strategic Advisory …” published on January 04, 2017 as well as Globenewswire.com‘s news article titled: “Applied DNA Sciences to Present at the 5th Annual Liolios Gateway Conference …” with publication date: August 23, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.